| Trial ID: | L0241 |
| Source ID: | NCT02235233
|
| Associated Drug: |
Technetium Tc 99M Mebrofenin
|
| Title: |
Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Steatohepatitis
|
| Interventions: |
Drug: Technetium Tc 99M Mebrofenin
|
| Outcome Measures: |
Hepatic exposure (AUC0??????)|Systemic exposure (AUC0 ??????)|Cmax (hepatic)|Tmax (hepatic)|Xurine|CLuptake|CLrenal
|
| Sponsor/Collaborators: |
University of North Carolina, Chapel Hill|National Institute of General Medical Sciences (NIGMS)
|
| Gender: |
All
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
21
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science
|
| Start Date: |
April 2015
|
| Completion Date: |
July 2016
|
| Results First Posted: |
--
|
| Last Update Posted: |
May 5, 2017
|
| Locations: |
UNC Hospitals, Chapel Hill, North Carolina, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT02235233
|
